At MAD-ID 2025, William R Mikesell, PharmD, presented data showing 20% vs 16% treatment failure rates in doxycycline and minocycline groups.
William R. Mikesell, PharmD
Advertisement
PGY1 Pharmacy Resident at Indiana University
Articles by William R. Mikesell, PharmD
Advertisement
Latest Updated Articles
No Significant Difference Between Doxycycline and Minocycline for Bone and Joint InfectionsPublished: June 4th 2025 | Updated:
Advertisement
Advertisement
Trending on Contagion Live
1
Oral Carbapenem Tebipenem HBr Demonstrates Non-Inferiority to IV Therapy in Phase III PIVOT-PO Trial
2
Introducing Cefiderocol Earlier in Difficult-to-Treat-Infections
3
Dynavax Presents Data for Shingles Vaccine, Launches Head-to-Head Study Against Shingrix
4
New Data Highlight Adult Pneumococcal Serotypes with Greater Antibiotic Resistance and Disease Burden Covered by Merck’s Vaccine
5
